Stock Ratings / Health Care / HYFT / dividends

NMAD (33) BOLD (41) ONCY (45) RFL (16) ⌘ Pro Terminal →

MindWalk Holdings Corp. (HYFT) Dividend Safety Gauge & 10-Year DRIP Compounder

$1.13 -5.83% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $1.12

MindWalk Holdings Corp. (HYFT) carries a Roarable Rating of D+ (Sell) with 58/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

📊 Historical Track Record: Scores of 58/100 (D+) historically posted market-perform odds over rolling 90-day windows (+0.0% avg 90D alpha vs SPY) →

ROARABLE D+ • SELL / AVOID Cap $57.1M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on HYFT Below — or Connect Your Own ChatGPT / Claude

🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is HYFT stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

▼

As of 2026-11-02, MindWalk Holdings Corp. (NASDAQ: HYFT) is rated D+ (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 58/100 at a spot price of $1.13 (-5.83% 1D, market cap $57.1M). Pillar breakdown: Fundamental Cash Engine 12/20, Institutional 13F & Options Flow 11/20, Executive Insider Alignment 13/20, FRED Macro Regime Fit 13/20, and SEC Balance-Sheet Forensics 9/20. Across 1016 tracked Health Care issuers, HYFT ranks #203 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief

🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does HYFT compare to NMAD and BOLD in the Health Care sector?

▼

Within the Health Care sector (Biotechnology: Pharmaceutical Preparations), HYFT carries a Roarable D+ (58/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of —. By comparison, NMAD (Nomad Power Solutions Inc.) holds a E grade (33/100 RQD, P/E N/A, ROIC -35.0%, cap $57.0M) and BOLD (Boundless Bio Inc.) posts a D- grade (41/100 RQD, P/E N/A, ROIC -35.0%, cap $57.3M). Among the 5-stock peer group, HYFT leads on earnings multiple (N/A) while NMAD leads on capital efficiency (-35.0% ROIC).

✓ Pre-computed one-to-many AI Quant brief

🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for HYFT?

▼

For MindWalk Holdings Corp. (HYFT), key quantitative strengths include Established market leader in Health Care with deep daily trading liquidity. and sector rank #203 in Health Care, while primary risk factors center on Company executives have done more routine share selling than personal cash buying lately. and implied 5-year growth hurdle of 8.0%/yr. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief

🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $1.12 (-1.24%)🧬 Disciplined Float (-0.40% YoY Shares)⚙️ Cash Engine: 12/20 (C-) • 0% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record: Scores of 58/100 (D+) historically posted market-perform odds over rolling 90-day windows (+0.0% avg 90D alpha vs SPY • 52.7% hit rate — wait for RQD ≥ 70 breakout).

Audit Bucket Track Record →

RQD QUANT TACHOMETERSELL / AVOID • D+

JEV AI Jury Split (Battleground)

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D+ · Rk C

Each axis scored 0–20

12M PRICE TARGET CONE+0% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for HYFT)Realized 20D OHLCV Swing Band: ±12.5%

Deterministic 5-Pillar Attribution (58/100 Composite)

🔍 WHY HYFT SCORES 58/100 (D+) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: SEC 10-K Forensic Risk+13/20 pts (22% of score)

Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 7/9

▲ #2 Bullish Driver: Macro Regime Fit+13/20 pts (22% of score)

FRED Regime × Technicals: 7% of 52W Range • RSI-14 at 36.8 (NEUTRAL RANGE)

▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution9/20 pts (-11 pt drag)

Disciplined Float (-0.40% YoY Shares) & executive Form 4 sales trim 11 pts from alignment

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade B-$1.50-12.7% Next Q

Q2 (-2Q)

Grade C+$1.31-11.5% Next Q

Q3 (-1Q)

Grade C$1.16-2.6% Next Q

Current

Grade D+$1.13+0% Hist 90D α

Trajectory: B- (66) → D+ (58)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

⚔️ Adversarial Opposing Case: Why the HYFT Bull Thesis Could Fail

Gideon Ashmere Forensic Desk →

Even with a 58/100 (D+) score, HYFT faces multiple-compression risk if current valuation multiples re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Company executives have done more routine share selling than personal cash buying lately.

⚠️ Forensic Kill-Switch #2

Dilution & Margin Drag: Disciplined Float (-0.40% YoY Shares) — any gross margin slip below 49.5% triggers an automatic RQD downgrade.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($1.34) or 200D SMA ($1.40) invalidates the momentum regime and cuts Target Base ($1.13) toward Bear Floor ($0.88).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $HYFT• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “HYFT Beats Next Quarter EPS Consensus (Upcoming Quarter) & Holds Above 200D SMA”

YES 58%NO 42%Trade / Inspect Odds →

CASH DIVIDEND + BUYBACK YIELD

1.8% Total Yield

0% Cash ($0.00/yr) + 1.8% Buybacks

PAYOUT SAFETY SPEEDOMETER

74/100 • REINVESTING IN GROWTH + BUYBACKS

FREE CASH FLOW PAYOUT RATIO

0% (100% Reinvested)

Retains cash flow for R&D and share repurchases

INTERACTIVE DRIP & SHAREHOLDER-YIELD COMPOUNDER (6.8% EST. ANNUAL)

$10,000 Compounded Over 10 Years → $19,307

Est. Year-10 Shareholder Yield: $348/yr

Starting Investment: $10,000

Compounding Horizon: 10 Years

$10.7K

Yr 1

$11.4K

Yr 2

$12.2K

Yr 3

$13.0K

Yr 4

$13.9K

Yr 5

$14.8K

Yr 6

$15.8K

Yr 7

$16.9K

Yr 8

$18.1K

Yr 9

$19.3K

Yr 10

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring HYFT)

✓Walkthrough of HYFT's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

HYFT // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -5.04%📐 HORIZONTAL RANGE

2026-10-30O $1.16H $1.21L $1.10C $1.13VOL 195.3K

RES: $1.90SUP: $1.01SMA50: $1.34SMA200: $1.40

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

HYFT Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 HYFT Butterfly Map → + Track HYFT →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

8.0%/yr Implied 5Y Growth

vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on HYFT today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for HYFT. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for HYFT today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (HYFT)

Health Care Rank #203 of 1016 ⚔️ NMAD vs HYFT Full Matrix →

1. Head-to-Head Health Care Peer Comparison (HYFT vs. NMAD, BOLD, ONCY, RFL)

Industry: Biotechnology: Pharmaceutical Preparations (489 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, MindWalk Holdings Corp. (HYFT) ranks #203 by composite RQD confidence (58/100, grade D+) and #729 by equity capitalization ($57.1M). Within this direct 5-issuer industry benchmark cohort, HYFT leads on earnings valuation at N/A trailing P/E, while NMAD leads on capital efficiency and profitability with -35.0% ROIC and — gross margin. HYFT currently leads its immediate peer cohort in composite quantitative strength at 58/100 (D+).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
HYFT ACTIVE MindWalk Holdings Corp.	D+	58/100	—	—	—	-5.83%	$57.1M	Benchmark Subject
NMAD Nomad Power Solutions Inc.	E	33/100	—	—	-35.0%	+0.56%	$57.0M	/nmad-vs-hyft →
BOLD Boundless Bio Inc.	D-	41/100	—	—	-35.0%	-0.40%	$57.3M	/bold-vs-hyft →
ONCY Oncolytics Biotech Inc.	D	45/100	—	—	-35.0%	-0.54%	$56.1M	/oncy-vs-hyft →
RFL Rafael Holdings Inc. (Class B)	E	16/100	—	—	-35.0%	-3.57%	$58.2M	/rfl-vs-hyft →

2. HYFT Fundamental Profitability, Capital Efficiency & Balance-Sheet Forensics

TRAILING 12M & FORWARD QUANTITATIVE SNAPSHOT

MindWalk Holdings Corp. (HYFT) operates in Biotechnology: Pharmaceutical Preparations (Health Care) with an equity capitalization of $57.1M, trailing P/E of N/A, forward P/E of N/A, and EV/EBITDA of N/A. Operating profitability registers a gross margin of —, operating margin of —, net profit margin of —, ROIC of —, and free cash flow yield of —, alongside an Altman Z-Score of N/A and Piotroski F-Score of N/A.

3. HYFT Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is HYFT stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

How does HYFT compare to NMAD and BOLD in the Health Care sector?

What are the biggest fundamental strengths and SEC risk factors for HYFT?

Where is HYFT trading relative to its 50-day, 200-day, and 52-week technical levels?

HYFT last traded at $1.13 (-5.83% on volume of 195,333 shares), positioning the stock -15.67% below its 50-day simple moving average ($1.34) and -19.29% below its 200-day simple moving average ($1.40). Across its 52-week range of $0.99 to $2.99, HYFT sits at the 7.0% percentile with a 14-day RSI of 36.8 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($1.00 to $1.27).

HYFT Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

Does HYFT pay a dividend and is it safe?

MindWalk Holdings Corp. (HYFT) offers a 0% cash dividend yield ($0.00 annualized) and 1.8% total shareholder yield including buybacks. Roarable rates its payout coverage as REINVESTING IN GROWTH + BUYBACKS.

Direct Sub-Reports: HYFT RQD Cockpit HYFT 12M Forecast HYFT Earnings & Move HYFT Dividends & DRIP HYFT Insiders & 13F HYFT Whale Options HYFT Profit Sankey HYFT News & Why